Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Dr Sion Scott
sion.scott@uea.ac.uk


Prof Debi Bhattacharya
D.Bhattacharya@uea.ac.uk


Study Location:

Find another location


Questions to ask
Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - A study testing if a new support package used in medication reviews helps patients take their medicines as prescribed
Back

A study testing if a new support package used in medication reviews helps patients take their medicines as prescribed

Recruiting

Open to: All Genders

Age: Mixed

Nottingham Strensall Bradford Cambridge

Medical Conditions

Cardiovascular, medication non-adherence, hypertension

This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


One in two people don’t take their medicines as prescribed for different reasons. Healthcare professionals (HCPs) in general practice surgeries do medication reviews to make sure a patient’s medicines are right for them and support them to take them as prescribed. But patients and HCPs often struggle to work out a person’s main reasons for not taking medicines as prescribed. This makes it difficult for them to find the right solutions.
Working with patients, HCPs and researchers, we developed the Identification of Medication Adherence Barriers Questionnaire (IMAB-Q). IMAB-Q has 10 questions for patients to answer before a medication review. Their answers tell the HCP the patient’s main reasons for not taking their medicines as prescribed. Each IMAB-Q question is linked to solutions specific to the reason for not taking medicines as prescribed. These solutions are delivered by the HCP during the medication review.
This study aims to test whether the support package that we have developed for general practice teams gives them everything they need to help HCPs to deliver IMAB Qi in their usual medication review processes. We also want to test whether we can collect all the research information that we need to be able to measure whether IMAB-Qi works and is good value for money for the NHS. We will be doing the testing in four general practices across England. This information will mean that we can properly prepare for a larger future trial.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

01 May 2026 31 Aug 2026

Ninety-six patient participants will be recruited during the recruitment period, from four participating practices. Patient records will be used to identify eligible patients. Eligible patients will be invited to sign a consent form and complete some questionnaires at baseline, week 1 and week 12; to attend a medication review during the study period and to provide blood pressure readings at three timepoints: baseline, week 4 and week 12. Patient participants will have the option to have their medication review recorded so the researchers can see how the new medication review approach works, and the option to participate in a conversation about their experience with one of the researchers via phone or video link. Some staff participants will set up and deliver the study at their practice, and others will be trained to set up and deliver IMAB-Qi to patients who meet the eligibility criteria. All staff will be invited to complete a demographics questionnaire and to participate in an interview or focus group.


Adults who are 18 years and older on the hypertension register can participate as long as they are taking at least one hypertensive medication, have a recent blood pressure reading that exceeds the age-related targets in the National Institute for Health and Care Excellence (NICE) guidelines, are due a medication review at their GP practice during the study period, and do not fall under any of the exclusion criteria. Practice staff will also participate, including HCPs delivering medication reviews and staff involved in the setup of the study and implementation of the intervention at sites.

You can take part if:



You may not be able to take part if:


GP practices:General practices with <5% of their patient population prescribed an antihypertensive medicines

Healthcare professionals (HCPs) involved with IMAB-Qi delivery:Healthcare professionals who conduct only disease-specific medication reviews, e.g., annual diabetes reviews

Patient participants:1. Not self-administering their medications2. Excepted from NICE guideline age-related blood pressure target because it is inappropriate, e.g., receiving end-of-life care, on maximal tolerated doses of medication, declined treatment3. On the severe mental illness register (IMAB-Q is not validated in this population)4. Deemed by the practice staff to lack capacity to understand the study and unable to make a decision regarding participating5. Under the care of a secondary care HCP for treatment of hypertension6. Pregnant, lactating or known to be planning pregnancy during the study


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Chilwell Valley and Meadows Practice, Chilwell Meadows Surgery
    Ranson Road Chilwell Beeston
    Nottingham
    NG9 6DX
  • MyHealth Group
    Southfields Road
    Strensall
    YO32 5UA
  • The Ridge Medical Practice
    Cousen Road
    Bradford
    BD7 3JX
  • Monkfield Medical Practice
    Sackville House Sackville Way Great Cambourne
    Cambridge
    CB23 6HL

There may not be any direct benefits to participants, although participants in the intervention sites may find that they are better supported to take their medications as prescribed.
Participants will be helping the research team learn if they can run a bigger study in the future to improve care for people with high blood pressure. The researchers do not think there are any risks in taking part in this study.

Prof Debi Bhattacharya
D.Bhattacharya@uea.ac.uk


Dr Sion Scott
sion.scott@uea.ac.uk



The study is sponsored by University of East Anglia and funded by National Institute for Health and Care Research.



We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?
Read full details for Trial ID: ISRCTN10873363

Or CPMS: 68555

Last updated 01 May 2026

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.   

Back to the top